A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
Kiemeney LA; Sulem P; Besenbacher S; Vermeulen SH; Sigurdsson A; Thorleifsson G; Gudbjartsson DF; Stacey SN; Gudmundsson J; Zanon C; Kostic J; Masson G; Bjarnason H; Palsson ST; Skarphedinsson OB; Gudjonsson SA; Witjes JA; Grotenhuis AJ; Verhaegh GW; Bishop DT; Sak SC; Choudhury A; Elliott F; Barrett JH; Hurst CD; de Verdier PJ; Ryk C; Rudnai P; Gurzau E; Koppova K; Vineis P; Polidoro S; Guarrera S; Sacerdote C; Campagna M; Placidi D; Arici C; Zeegers MP; Kellen E; Gutierrez BS; Sanz-Velez JI; Sanchez-Zalabardo M; Valdivia G; Garcia-Prats MD; Hengstler JG; Blaszkewicz M; Dietrich H; Ophoff RA; van den Berg LH; Alexiusdottir K; Kristjansson K; Geirsson G; Nikulasson S; Petursdottir V; Kong A; Thorgeirsson T; Mungan NA; Lindblom A; van Es MA; Porru S; Buntinx F; Golka K; Mayordomo JI; Kumar R; Matullo G; Steineck G; Kiltie AE; Aben KK; Jonsson E; Thorsteinsdottir U; Knowles MA; Rafnar T; Stefansson K; Nature Genetics, 2010, vol. 42, issue 5, p 415, ISSN 15461718. ISBN 15461718.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef